Welcome to the Olmesartan Products Resolution Program Website

This is the official website for the Olmesartan Products Resolution Program, a private settlement program established for the purpose of resolving Claims related to Olmesartan Products, including those pending in these proceedings as of August 1, 2017:                         


1.   In Re: Benicar (Olmesartan) Products Liability Litigation, MDL No. 2606 (the “MDL”), a federal multi-district litigation venued in the United States District Court for the District of New Jersey;

2.   Any other federal court proceedings, either pending in that court or awaiting transfer to the MDL;

3.   In re: Benicar (Olmesartan Medoxomil), Case No. 299, venued in the Superior Court of New Jersey, Law Division: Atlantic County; and

4.   Any and all other state court proceedings.


Important Dates

MDL and New Jersey Coordinating Court Census Order Deadline
August 25, 2017

Supplemental Census for Registered Unfiled Claims Deadline
December 1, 2017
Opt In Deadline
April 2, 2018
Effective Date
11:59 PM ET on the 30th day following the last Opt In Deadline attributable to any Eligible Enrollee 

Claimants with Claims that have not yet been filed in any jurisdiction are also eligible to participate in the Program as set out in the Settlement Agreement.

CENSUS DEADLINE: THE CENSUS DEADLINE WAS AUGUST 25, 2017. The deadline to provide the Claims Administrator with complete Census information on all Olmesartan Products-related cases and Claims, whether filed or unfiled, and regardless of whether such Claims are eligible for enrollment into or payment under the Olmesartan Products Resolution Program was August 25, 2017.


ENROLLMENT: We have temporarily removed the Enrollment functions as instructed by the Parties.  


SUPPLEMENTAL CENSUS DEADLINE FOR REGISTERED UNFILED CLAIMS:  The deadline to complete the Supplemental Census for Registered Unfiled Claimants was December 1, 2017